⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28777937 | 0.59 | — | — | |
| SCHEMBL2439268 | 0.56 | — | — | |
| Methylisothiocyanate SCHEMBL3152 | 0.56 | — | — | |
| SCHEMBL9617070 | 0.56 | — | — | |
| SCHEMBL452053 | 0.56 | — | — | |
| SCHEMBL344363 | 0.56 | — | — | |
| SCHEMBL1534324 | 0.56 | — | — | |
| SCHEMBL14164129 | 0.56 | — | — | |
| SCHEMBL16970720 | 0.56 | — | — | |
| SCHEMBL6653692 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115093418-A | [1,2,3] triazolo [4,5-d ] pyrimidine derivatives having affinity for cannabinoid type 2 receptors | 豪夫迈·罗氏有限公司 | 2022-09-23 | — | — | CN | claimed |
| CN-115073476-A | [1,2,3] triazolo [4,5-d ] pyrimidine derivatives having affinity for cannabinoid type 2 receptors | 豪夫迈·罗氏有限公司 | 2022-09-20 | — | — | CN | claimed |
| CN-109311886-B | [1,2,3] triazolo [4,5-d ] pyrimidine derivatives | 豪夫迈·罗氏有限公司 | 2021-11-09 | — | — | CN | claimed |
| US-10457685-B2 | [1,2,3]triazolo[4,5-D]pyrimidine derivatives with affinity for the type-2 cannabinoid receptor | HOFFMANN-LA ROCHE INC. (US) | 2019-10-29 | — | — | US | claimed |
| US-10450321-B2 | [1,2,3]triazolo[4,5-D]pyrimidine derivatives | HOFFMANN-LA ROCHE INC. (US) | 2019-10-22 | — | — | US | claimed |
| US-20190127384-A1 | [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES WITH AFFINITY FOR THE TYPE-2 CANNABINOID RECEPTOR | HOFFMANN-LA ROCHE INC. (US) | 2019-05-02 | — | — | US | claimed |
| US-20190127385-A1 | NOVEL [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2019-05-02 | — | — | US | claimed |
| EP-3475282-A1 | [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES WITH AFFINITY FOR THE TYPE-2 CANNABINOID RECEPTOR | H. Hoffnabb-La Roche Ag (CH) | 2019-05-01 | — | — | EP | claimed |
| EP-3475281-A1 | NOVEL [1,2,31TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES | H. Hoffnabb-La Roche Ag (CH) | 2019-05-01 | — | — | EP | claimed |
| WO-2018015088-A1 | NOVEL [1,2,31TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2018-01-25 | — | — | WO | claimed |
| EP-2591673-A1 | PEST CONTROL AGENT | Meiji Seika Pharma Co., Ltd. (JP) | 2013-05-15 | — | — | EP | claimed |
| US-20130102637-A1 | PEST CONTROL AGENT | GIFU UNIVERSITY (JP) | 2013-04-25 | — | — | US | claimed |
| EP-2563508-A2 | DELIVERY PARTICLE | The Procter & Gamble Company (US) | 2013-03-06 | — | — | EP | claimed |
| US-8309733-B2 | Imino derivatives, methods for producing the same and insecticides containing the same | Meji Seika Pharma Co., Ltd. (JP) | 2012-11-13 | — | — | US | claimed |
| US-20110268802-A1 | DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY | 2011-11-03 | — | — | US | claimed |
| US-20110172433-A1 | NOVEL IMINO DERIVATIVES, METHODS FOR PRODUCING THE SAME AND INSECTICIDES CONTAINING THE SAME | MEIJI SEIKA KAISHA, LTD. (JP) | 2011-07-14 | — | — | US | claimed |
| EP-2305658-A1 | NOVEL IMINO DERIVATIVE, PROCESS FOR PRODUCTION OF THE SAME, AND PESTICIDE COMPRISING THE SAME | Meiji Seika Kaisha, Ltd. (JP) | 2011-04-06 | — | — | EP | claimed |
| WO-2010079468-A2 | DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-15 | — | — | WO | claimed |
| US-5663164-A | CEPHALOSPORIN ANTIBIOTICS AS BACTERICIDES | ROUSSEL UCLAF (FR) | 1997-09-02 | — | — | US | claimed |
| EP-0153229-A2 | 1-Dethia 2-thia-cephalosporanic acid derivatives, process and intermediates for their preparation, their use as therapeutic agents and the compositions containing them | ROUSSEL-UCLAF (FR) | 1985-08-28 | — | — | EP | claimed |